Zepbound 5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FN0P8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $132,402
Award facts
- Contract value 100% obligated
- $132,401.74 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 20, 2026, the Defense Logistics Agency awarded a delivery order valued at $132,401.74 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pens. The contract employs firm fixed-price pricing and is classified as a non-set-aside award, indicating competitive selection. Performance will be completed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of January 21, 2026. This delivery order is issued under AmerisourceBergen Drug Corp's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 31, 2031, which serves as the primary vehicle for pharmaceutical and medical supply distribution to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement needs across military and veteran healthcare systems. The company's federal contracting history demonstrates extensive capability in delivering a comprehensive range of pharmaceutical products, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This specific award for Zepbound, a prescription medication used in diabetes and weight management treatment, reflects the company's ongoing role in supporting the Defense Health Agency and other government healthcare systems through the DLA's pharmaceutical supply chain infrastructure.
Quick answers
Who was awarded contract SPE2DR26FN0P8?
SPE2DR26FN0P8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26FN0P8 worth?
The government has obligated $132,402 on SPE2DR26FN0P8.
Is contract SPE2DR26FN0P8 an order under another contract?
Yes. SPE2DR26FN0P8 is a delivery order under SPE2DR25D2211, an indefinite delivery contract.
Was contract SPE2DR26FN0P8 competed?
The extent of competition for SPE2DR26FN0P8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award